Biological evaluation of alpha -TCP/TCCP composite bone cement

alpha -tricalcium phosphate ( alpha TCP)/tetracalcium phosphate (TCCP) composite bone cement had good hydration characteristic. In our system, alpha -TCP/TTCP powder mixture was mixed water at a powder /liquid (P/L) ratio of 1.50g times mL super(-1). The setting time could be adjusted, the maximum c...

Full description

Saved in:
Bibliographic Details
Published inJournal of Wuhan University of Technology. Materials science edition Vol. 17; no. 3; pp. 35 - 38
Main Authors Dai, Hong-Lian, Yan, Yu-Hua, Wang, You-Fa, Zhou, Xue-Dong, Yu, Guo-Rong
Format Journal Article
LanguageEnglish
Published 01.09.2002
Online AccessGet full text

Cover

Loading…
More Information
Summary:alpha -tricalcium phosphate ( alpha TCP)/tetracalcium phosphate (TCCP) composite bone cement had good hydration characteristic. In our system, alpha -TCP/TTCP powder mixture was mixed water at a powder /liquid (P/L) ratio of 1.50g times mL super(-1). The setting time could be adjusted, the maximum compressive strength was 45.36MPa, and the hydration product was hydroxyapatite (HAP). In vitro biological simulated experiments indicate that alpha -TCP/TTCP bone cement has a certain dissolubility. The hardened product is mainly HAP after soaking in simulated body fluid (SBF) for 10 weeks. The results of in vitro test and animal experiments and SEM analyses show that no local or general toxicity response, no muscle stimulation, no haemolysis, no cruor, no inflammatory reaction and no exclusion response are caused by alpha -TCP/TTCP cement, which can be contributed to bone tissue spreading and impringing. alpha -TCP/TTCP cement hydrated and hardened continually in vivo. The materials fused with host bone together with implanting time prolonging. Therefore, it is believed that alpha -TCP/TTCP composite bone cement has a high biocompatibility and bioactivity, a certain biodegradation and good osteogenesis as well.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1000-2413
DOI:10.1007/BF02838535